Other Solid Tumors Recruiting Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04256707Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination TreatmentTreatment